Suppr超能文献

甘露寡糖补充对 C57Bl/6J 小鼠体重增加和脂肪积累的影响。

The effect of mannan oligosaccharide supplementation on body weight gain and fat accrual in C57Bl/6J mice.

机构信息

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Obesity (Silver Spring). 2010 May;18(5):995-9. doi: 10.1038/oby.2009.308. Epub 2009 Oct 1.

Abstract

The prevalence of obesity in industrialized societies has become markedly elevated. In contrast, model organism research shows that reducing caloric intake below ad libitum levels provides many health and longevity benefits. Despite these benefits, few people are willing and able to reduce caloric intake over prolonged periods. Prior research suggests that mannooligosaccharide (MOS or mannan) supplementation can increase lifespan of some livestock and in rodents can reduce visceral fat without reducing caloric intake. Hence, we tested the effect of MOS supplementation as a possible calorie restriction (CR) mimetic (CRM) in mice. C57Bl/6J male mice were fed a high-fat "western" type diet with or without 1% MOS (by weight) supplementation (n = 24/group) from 8 to 20 weeks of age. Animals were housed individually and provided 95% of ad libitum food intake throughout the study. Body weight was measured weekly and body composition (lean and fat mass) measured noninvasively every 3 weeks. Individual fat depot weights were acquired by dissection at study completion. Supplementation of a high-fat diet with 1% MOS tended to reduce total food intake (mean +/- s.d.; control (CON): 293.69 +/- 10.53 g, MOS: 288.10 +/- 11.82 g; P = 0.09) during the study. Moreover, MOS supplementation had no significant effect on final body weight (CON: 25.21 +/- 2.31 g, MOS: 25.28 +/- 1.49 g; P = 0.91), total fat (CON: 4.72 +/- 0.90 g, MOS: 4.82 +/- 0.83 g; P = 0.69), or visceral fat (CON: 1.048 +/- 0.276 g, MOS: 1.004 +/- 0.247 g; P = 0.57). Contrary to previous research, MOS supplementation had no discernable effect on body weight gain or composition during this 12-week study, challenging the potential use of MOS as a CRM or body composition enhancer.

摘要

在工业化社会中,肥胖的患病率显著升高。相比之下,模式生物研究表明,将热量摄入减少到自由进食水平以下会带来许多健康和长寿益处。尽管有这些好处,但很少有人愿意并能够长期减少热量摄入。先前的研究表明,甘露寡糖 (MOS 或甘露聚糖) 补充剂可以延长一些牲畜的寿命,并且在啮齿动物中可以在不减少热量摄入的情况下减少内脏脂肪。因此,我们测试了 MOS 补充剂作为可能的热量限制 (CR) 模拟物 (CRM) 在小鼠中的作用。从 8 到 20 周龄,C57Bl/6J 雄性小鼠用高脂肪“西方”型饮食喂养,或用 1% MOS(按重量)补充剂喂养(每组 24 只)。动物单独饲养,在整个研究过程中提供 95%的自由进食量。每周测量体重,每 3 周非侵入性测量身体成分(瘦体重和脂肪量)。研究结束时通过解剖获得各个脂肪储存重量。高脂肪饮食中补充 1% MOS 会减少总食物摄入量(平均值 +/- 标准差;对照 (CON):293.69 +/- 10.53 g,MOS:288.10 +/- 11.82 g;P = 0.09)。此外,MOS 补充剂对最终体重没有显著影响(CON:25.21 +/- 2.31 g,MOS:25.28 +/- 1.49 g;P = 0.91)、总脂肪(CON:4.72 +/- 0.90 g,MOS:4.82 +/- 0.83 g;P = 0.69)或内脏脂肪(CON:1.048 +/- 0.276 g,MOS:1.004 +/- 0.247 g;P = 0.57)。与之前的研究相反,MOS 补充剂在这 12 周的研究中对体重增加或组成没有明显影响,这对 MOS 作为 CRM 或身体成分增强剂的潜在用途提出了挑战。

相似文献

引用本文的文献

本文引用的文献

3
4
Visceral adipose tissue modulates mammalian longevity.内脏脂肪组织调节哺乳动物的寿命。
Aging Cell. 2008 Jun;7(3):438-40. doi: 10.1111/j.1474-9726.2008.00391.x. Epub 2008 Mar 18.
6
Surgical treatment of obesity.肥胖症的外科治疗
Nat Clin Pract Endocrinol Metab. 2007 Aug;3(8):574-83. doi: 10.1038/ncpendmet0563.
7
Caloric restriction in humans.人类的热量限制。
Exp Gerontol. 2007 Aug;42(8):709-12. doi: 10.1016/j.exger.2007.03.009. Epub 2007 Mar 31.
9
The obesity epidemic: current and future pharmacological treatments.肥胖流行:当前及未来的药物治疗
Annu Rev Pharmacol Toxicol. 2007;47:565-92. doi: 10.1146/annurev.pharmtox.47.120505.105256.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验